Nitrosyl-heme and Heme Iron Intake from Processed Meats and Risk of Colorectal Cancer in the EPIC-Spain Cohort
Authors:
- Lucía Rizzolo-BrimeLRLucía Rizzolo-Brime
- Leila Lujan-BarrosoLLLeila Lujan-Barroso
- Andreu Farran-CodinaAFAndreu Farran-Codina
- Ricard BouRicard Bou
- Cristina LasherasCLCristina Lasheras
- Pilar AmianoPAPilar Amiano
- Amaia AizpuruaAAAmaia Aizpurua
- Maria-Jose SánchezMSMaria-Jose Sánchez
- Esther Molina-MontesEMEsther Molina-Montes
- Marcela GuevaraMGMarcela Guevara
- Conchi Moreno-IribasCMConchi Moreno-Iribas
- Alba GasqueAGAlba Gasque
- 28 March 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 33 (6) , 854-856
Abstract
Background: The International Agency for Research on Cancer classified processed meats (PM) as “carcinogenic” and red meat as “probably carcinogenic” for humans. The possible relationship between colorectal cancer risk and the mechanisms involved in the carcinogenesis of PMs have not been established yet. Nitrosyl-heme and heme iron have been proposed as potential-related compounds. The aim of this study was to determine the association between nitrosyl-heme and heme iron intake and colorectal cancer risk among participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain study. Methods: This prospective study included 38,262 men and women from the EPIC-Spain study. Food consumption was assessed using diet history and food composition tables. Heme iron and nitrosyl-heme intake were determined by estimating the intake of PM items and conducting laboratory analyses. HR estimates were obtained by proportional hazard models, stratified by age at recruitment and study center and adjusted for sex, total energy intake, education, smoking, body mass index, waist size, physical activity, lifetime alcohol, fibre, calcium, and familiar colorectal cancer history. Results: During a mean follow-up of 16.7 years, 577 participants were diagnosed with colorectal cancer. We found no overall association between nitrosyl-heme [HRT3vsT1, 0.98; 95% confidence interval (CI), 0.79–1.21] or heme iron intakes (HRT3vsT1, 0.88; 95% CI, 0.70–1.10) with colorectal cancer risk, nor according to tumor subtypes. Conclusions: Our study found no evidence supporting a link between nitrosyl-heme or heme iron intake and colorectal cancer risk in Spanish subjects. Impact: As research on nitrosyl-heme is preliminary, more heterogeneous studies are necessary to provide more convincing evidence on their role in colorectal cancer carcinogenesis.Keywords
Funding Information
- Instituto de Salud Carlos III (PI19/00817)
- Instituto de Salud Carlos III (FI20/00006)
This publication has 7 references indexed in Scilit:
- Iron, heme, and nitrosyl-heme content in Spanish meat derivativesJournal of Food Composition and Analysis, 2023
- Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort studyBritish Journal of Cancer, 2023
- Heme Iron Intake, Dietary Antioxidant Capacity, and Risk of Colorectal Adenomas in a Large Cohort Study of French WomenCancer Epidemiology, Biomarkers & Prevention, 2016
- Carcinogenicity of consumption of red and processed meatThe Lancet Oncology, 2015
- Processed Meat and Colorectal Cancer: A Review of Epidemiologic and Experimental EvidenceNutrition and Cancer, 2008
- The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC studyEuropean Journal of Clinical Nutrition, 2007
- European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collectionPublic Health Nutrition, 2002